According to the definition and definition of pharmaceutical equipment, pharmaceutical equipment refers to mechanical equipment mainly used in pharmaceutical processes, also known as pharmaceutical machinery
.
According to the subdivision classification, pharmaceutical equipment can be divided into API equipment, preparation machinery, drinking piece machinery, drug testing equipment, pharmaceutical crushing machinery, pharmaceutical packaging machinery, pharmaceutical water equipment and other pharmaceutical equipment
.
The upstream of the pharmaceutical equipment industry is steel, mechanical parts, electrical parts and other industries, and the downstream is for chemical APIs, Chinese medicine tablet processing, biopharmaceutical and other industries, and the development of its downstream industries has a significant impact
on the development of the pharmaceutical equipment industry.
This is mainly a brief analysis of the development prospects of China's pharmaceutical equipment industry in 2023, for reference in the industry only
.
Pharmaceutical equipment industry (Image source: Pharmaceutical Network)
Overview of the overall development of the industry in 2022
In 2022, the rapid development of biological drugs such as vaccines and biological drugs, and the expansion of demand for high-end pharmaceutical equipment and consumables have brought a new round of opportunities
to the industry.
At the same time, under the promotion of medical reform policies such as drug consistency evaluation and centralized procurement, drug industry standards have been continuously improved, forcing pharmaceutical equipment to be continuously upgraded
.
In this context, in 2022, pharmaceutical machine companies represented by leading enterprises such as Dongfulong and Chutian Technology have actively combined the development needs of the biopharmaceutical industry, increased investment in the research and development of high-end pharmaceutical equipment, accelerated the pace of domestic substitution, and further met the needs
of pharmaceutical companies.
From the perspective of the profitability of the pharmaceutical equipment industry in 2022, the industry as a whole has maintained a steady growth trend, among which the performance of the head enterprises is more eye-catching
.
In the first three quarters of 2022, the head enterprise Chutian Technology achieved double growth in revenue and net profit, of which the total operating income was 4.
495 billion yuan, a year-on-year increase of 22.
1%; The net profit attributable to the parent was 463 million yuan, a year-on-year increase of 15.
3%.
According to the third quarter report of Dongfulong in 2022, the company's main revenue was 3.
817 billion yuan, an increase of 32.
43% over the same period last year; net profit attributable to owners was RMB604 million, up 8.
29% year-on-year; Non-net profit was RMB566 million, up 10.
92%
year-on-year.
The overall development environment of the industry is good
From the perspective of the development environment of the pharmaceutical equipment industry, in terms of policy environment, with the continuous improvement of the medical system reform and social security mechanism, the policy is continuing to support and encourage the high-quality development
of the domestic pharmaceutical equipment industry, especially the high-end pharmaceutical equipment industry.
In 2022, China issued the "14th Five-Year Plan for the Development of the Pharmaceutical Industry", which pointed out that it is necessary to comprehensively improve the modernization level of the pharmaceutical industry chain, achieve a stable and controllable supply chain, and accelerate the transformation of innovation-driven development
.
After the release of the plan, it will further promote the high-quality innovation and development of the pharmaceutical industry, and at the same time force the upstream pharmaceutical equipment to transform and upgrade
in high-end directions such as automation and intelligence.
From the demand side, with the acceleration of urbanization, the aging of the population, the improvement of residents' medical expenditure, the market demand of the pharmaceutical equipment industry is continuing to expand, and the orders of leading enterprises have increased significantly
.
On the supply side, the technical level of the domestic pharmaceutical equipment industry is constantly improving, especially driven by the epidemic in recent years, the capabilities of domestic pharmaceutical machinery enterprises with strength have gradually been recognized in the market opportunity, and the competence circle of the head pharmaceutical equipment company continues to extend.
However, in terms of regulatory system, at present, the overall concentration of the domestic pharmaceutical equipment industry is not high, mostly small and medium-sized enterprises, the entire market presents small, scattered, chaotic characteristics, the industry due to the low threshold, but also lack of a perfect regulatory system, the market is mixed, need to be further improved, in order to promote industrial standardization, high-quality development
.
2023 will usher in an upward cycle
Looking forward to 2023, Zhongtai Securities said in a research report not long ago that in 2023, at the beginning of a new starting point, the market is expected to revolve around "recovery
".
Among them, in terms of innovation demand and the recovery of manufacturing, the bank believes that the disruption of pharmaceutical equipment orders will not change, and the medium and long-term logic is smooth, and pharmaceutical equipment has ushered in an upward cycle
.
In the medium and long term, with the aging of the population, consumption upgrades, pharmaceutical market demand will continue to increase, while domestic pharmaceutical equipment enterprises through continuous research and development investment, accelerate from the low-end market to the high-end market, domestic high-end pharmaceutical machine market penetration rate will be improved, the industry market scale will continue to expand, the industry predicts that the sales of the domestic pharmaceutical equipment industry in 2022 will exceed 23 billion yuan, and reach about
25 billion yuan by 2023.
In the face of considerable market space, pharmaceutical equipment enterprises need to seize the opportunity and maintain the pace of progress with the times, at present, intelligent, integrated, green, etc.
have become the development trend of the pharmaceutical equipment industry, pharmaceutical machinery enterprises should actively transform and upgrade
in these directions.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
